Skip to content

Pre clinical evaluation of Jieyu II granule in the treatment of depression

Pre clinical evaluation of Jieyu II granule in the treatment of depression

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000004134
Enrollment
Unknown
Registered
2020-09-25
Start date
2020-12-31
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Interventions

Sponsors

Shanghai Municipal Hospital Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1. Both male and female, aged from 18 to 70 years (including 18 and 70 years old). 2. According to the diagnosis of mild to moderate depression, the score of Hamilton Depression Scale (17 item version) was 7 to 17. 3. Sign written informed consent.

Exclusion criteria

Exclusion criteria: 1. The score of Hamilton Depression Scale (17 item version) was less than 7 or > 18; 2. Excluding organic mental disorders, or depression caused by psychoactive substances and non addictive substances; 3. Women who are pregnant, breastfeeding or may become pregnant during the study and are unable to take effective contraceptive measures; 4. Obvious symptoms of heart, liver, kidney or other systems; 5. Laboratory examination and ECG examination have obvious clinical significance abnormalities, which can affect the drug evaluation or the safety of the subjects; 6. AST and ALT were 2.0 times higher than the upper limit of normal value; 7. Participated in other clinical drug research in the last month.

Design outcomes

Primary

MeasureTime frame
Hamilton Depression Scale;

Countries

China

Contacts

Public ContactXu Hong

Shanghai Municipal Hospital Traditional Chinese Medicine

xuhong_67@163.com+86 18116013390

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026